General medical device registration · Southeast Asia

General Medical Device (GMD) Registration in Five ASEAN Markets

Active equipment, non-active consumables, implants, monitoring and therapeutic devices entering Singapore, Malaysia, Thailand, Vietnam and Indonesia face similar classification rules but different procedures. MediPass starts from your intended use, determines the risk class and pathway market by market, and files, holds and maintains the registration through our own licensed companies in all five countries.

Singapore HSA · Malaysia MDA · Thai FDA · Vietnam MoH · Indonesia MoH

Assess my classification and pathway See what we do →

Classification, grouping and pathway are three separate decisions

Manufacturers often convert the class on a CE certificate or home-market licence straight into a local class, or assume that a device that is not implanted and does not touch blood must be low risk. All five markets use a four-tier system, but tier names, the treatment of low-risk devices, assessment routes and the applicant entity differ. One wrong call changes the dossier, the budget and the launch date.

MediPass fixes the intended use first, then answers three questions for each market: which risk class the device falls into (classification); which models and accessories can share one application (grouping); and which assessment route that application takes (full, abridged or reliance on an existing approval). Each conclusion records the rule, clause and document version it rests on, and becomes the shared baseline for all five submissions.

Book a classification review

What we do for general medical devices

From regulatory scope to local licence holding, MediPass delivers the full registration through its own entities in five markets. A typical general medical device project runs through four steps.

Step 01Scope & class

Confirm regulatory scope and document the risk class for each market

We first confirm whether the product meets the local medical device definition; general devices, IVDs and standalone software follow different rule sets. We then test the device against each market’s classification rules (HSA GN-13, MDA/GD/0009, AMDD Annex 2 and the Vietnamese and Indonesian rules) on contact site, invasiveness, duration of use, energy and substance delivery and implantation, applying the highest class where several rules apply.

At the end of this step you have the risk class for each of the five markets, together with the classification rule each conclusion relies on, ready for pathway selection and dossier planning.

Step 02Grouping & route

Plan the application scope and assessment route

Same brand and same risk class are not enough to put several models in one application. We apply each market’s grouping rules (for example the FAMILY / SYSTEM / GROUP criteria in HSA GN-12-1) and check eligibility for abridged or reliance routes. Singapore and Thailand both offer reliance on reference-agency approvals, each with its own conditions that risk class alone does not settle.

Output: a market-by-market registration roadmap with number of applications, route, applicant entity, official fees and expected timelines.

Step 03Dossier & gaps

Map your evidence to CSDT and local requirements

All five markets build on the ASEAN CSDT, but labelling language, clinical evidence, biocompatibility, electrical safety and software documentation expectations differ. We map your existing technical file to each target market and mark what can be used as is, what needs explanation and what needs new testing.

Before quoting, we confirm whether the product can be filed in each target market; once the project starts we review the technical file item by item, so you know what is missing, who prepares it and how long it takes before anything is submitted.

Step 04Filing & holding

Filed and held by MediPass’s own companies in five markets

MediPass has its own licensed company in Singapore, Malaysia, Thailand, Vietnam and Indonesia. Each can act as applicant, authorised representative or local registration holder: submitting, answering regulator queries, maintaining the certificate and carrying post-market obligations. The registration stays independent of any distributor, so you keep control of your sales channels.

See the local entities and credentials in five markets.

Change of registrant and licence-holding services

Classification and registration requirements in five markets

All five markets use four risk tiers, but the handling of low-risk devices, the names of the procedures and the applicant entity differ. The table compares frameworks; the class of a specific device still has to be argued rule by rule in each market.

Market	Risk tiers	Market-entry procedure	Low-risk handling
Singapore	A / B / C / D	HSA product registration (Class B–D)	Class A exempt from product registration; dealers still need an HSA dealer’s licence
Malaysia	A / B / C / D	MDA product registration (Class A–D)	Class A exempt from CAB conformity assessment, but still registered with MDA
Thailand	Class 1 / 2 / 3 / 4	Listed (1) · Notified (2–3) · Licensed (4)	Class 1 still requires a Listed certificate
Vietnam	A / B / C / D	Class A, B: declaration number · Class C, D: registration certificate	Class A and B obtain a number through the declaration procedure
Indonesia	A / B / C / D	MoH marketing authorisation (izin edar)	Every class requires an izin edar

Singapore

HSA · Class A–DGN-13 risk classification of general medical devices

Class B, C and D devices require product registration. Class A is exempt from product registration, but importers and wholesalers still need an HSA dealer’s licence and carry post-market duties.